The axolotl (Ambystoma mexicanum) is a biological marvel that challenges standard amphibian metamorphosis. Most salamanders transition from aquatic larvae with external gills to terrestrial adults with functional lungs. However, axolotls retain their larval traits—including feathery gills, aquatic tails, and un-metamorphosed skin—throughout their entire adult life, a state called obligate neoteny.
The root cause of this perpetual youth lies within the hypothalamic-pituitary-thyroid (HPT) axis. In typical amphibians, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the pituitary gland to secrete thyroid-stimulating hormone (TSH). TSH then prompts the thyroid gland to produce thyroxine (T4) and triiodothyronine (T3), the crucial hormones that trigger metamorphosis.
In axolotls, while the thyroid gland is capable of producing T4 when stimulated artificially, the endogenous HPT axis fails to produce adequate TSH surges under normal conditions. Furthermore, target tissues in the axolotl exhibit reduced sensitivity to low hormone levels. When scientists inject axolotls with thyroid hormones or TSH, the animals undergo a drastic, stress-inducing metamorphosis: losing their gills, altering their skin structure, and transforming into terrestrial salamanders.
This evolutionary trade-off allowed axolotls to thrive in the stable, nutrient-rich high-altitude lake environments of Lake Xochimilco, avoiding the perils of land-based life.